Guangzhou Kaisheng Intelligent Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Guangzhou Kaisheng Intelligent Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include KENOSPHR. The owner is based in Guangzhou.
Xinkai Vil, Chengjiao St, Conghua Dist
No.100 Workshop East of Cheng'ao Ave
Guangzhou 510900 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangzhou Kaisheng Intelligent Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Guangzhou Kaisheng Intelligent Technology Co., Ltd. have?
Guangzhou Kaisheng Intelligent Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Guangzhou Kaisheng Intelligent Technology Co., Ltd. file in?
Guangzhou Kaisheng Intelligent Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Guangzhou Kaisheng Intelligent Technology Co., Ltd.'s most well-known trademarks?
Guangzhou Kaisheng Intelligent Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as KENOSPHR. These are among 1 currently registered trademark in the portfolio.
What is Guangzhou Kaisheng Intelligent Technology Co., Ltd.'s trademark registration success rate?
Guangzhou Kaisheng Intelligent Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.